NCT01382212
- Conditions
- Chronic Disease, Disease Attributes, End-stage Renal Disease, +16 more
- Locations
-
Not specified
Clinical trial condition
Hyperparathyroidism, Secondary
Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.
146 public trials
7 recruiting studies
Hyperparathyroidism, Secondary trial results
NCT00601328
- Conditions
- Calcium Metabolism Disorders, Endocrine System Diseases, Hyperparathyroidism, +7 more
- Locations
-
- Bio-Kinetic Clinical Applications, Inc. Springfield, Missouri, United States
NCT01134562
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +1 more
- Locations
-
- Cypress, California, United States
- Shreveport, Louisiana, United States
- Houston, Texas, United States
- Brisbane, Queensland, Australia
NCT02102204
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +1 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Alhambra, California, United States
- Research Site Azusa, California, United States
- Research Site Bakersfield, California, United States
NCT01922843
- Conditions
- Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
- Locations
-
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
- Washington D.C., District of Columbia, United States
- Evanston, Illinois, United States
NCT01653379
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- Tucson, Arizona, United States
- Tustin, California, United States
- Denver, Colorado, United States
- St Louis, Missouri, United States
Completed
Phase 3 Study of KHK7580
NCT02549404
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan
Completed
Phase 3 Study of KHK7580
NCT02549417
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan
NCT02830789
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- Department of Enodocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark
NCT02895061
- Conditions
- Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis, Endocrine System Diseases, Hyperparathyroidism, +2 more
- Locations
-
Not specified